Eledon Pharmaceuticals, Inc. (ELDN)
NASDAQ: ELDN · Real-Time Price · USD
1.550
-0.120 (-7.19%)
At close: Nov 26, 2025, 4:00 PM EST
1.560
+0.010 (0.65%)
After-hours: Nov 26, 2025, 7:23 PM EST
Eledon Pharmaceuticals Market Cap
Eledon Pharmaceuticals has a market cap or net worth of $116.48 million as of November 26, 2025. Its market cap has decreased by -60.69% in one year.
Market Cap
116.48M
Enterprise Value
23.80M
1-Year Change
-60.69%
Ranking
Category
Stock Price
$1.55
Market Cap Chart
Since May 11, 2017, Eledon Pharmaceuticals's market cap has increased from $44.66M to $116.48M, an increase of 160.82%. That is a compound annual growth rate of 11.86%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 26, 2025 | 116.48M | -52.67% |
| Dec 31, 2024 | 246.13M | 465.07% |
| Dec 29, 2023 | 43.56M | 38.87% |
| Dec 30, 2022 | 31.37M | -50.29% |
| Dec 31, 2021 | 63.09M | -72.98% |
| Dec 31, 2020 | 233.47M | 3,004.22% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| May 11, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 993.82B |
| Johnson & Johnson | 497.93B |
| AbbVie | 409.68B |
| UnitedHealth Group | 295.56B |
| AstraZeneca | 288.24B |
| Merck & Co. | 262.25B |
| Novartis AG | 248.38B |
| Thermo Fisher Scientific | 224.59B |